Skip to content

Clinical trials

Completed Phase 3 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Status: Completed Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20043
20055
20063
20071
20092
20111
20123
20131
20141
20153
20161
20171
20182
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
GlaxoSmithKline3
AO GENERIUM2
Eisai Inc.2
Pfizer2
Beijing Northland Biotech. Co., Ltd.1
CSL Behring1
Carelon Research1
Cerus Corporation1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia33
Purpura, Thrombocytopenic, Idiopathic18
Purpura, Thrombocytopenic6
Purpura4
Hematologic Diseases3
Hemorrhage3
Ecchymosis2
Hemostatic Disorders2
Blood Platelet Disorders1
Heart Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.